Hilary J Longhurst Selected Research

Hilary J Longhurst Research Topics

Disease

29	Hereditary Angioedemas 02/2024 - 04/2007
10	Angioedema 02/2024 - 09/2004
4	Infections 12/2014 - 01/2004
2	Rare Diseases (Rare Disease) 01/2022 - 02/2019
2	Hereditary Angioedema Types I and II 01/2019 - 11/2018
2	Lymphopenia (Lymphocytopenia) 05/2018 - 01/2017
1	Anaphylaxis (Anaphylactic Shock) 01/2022
1	Urticaria (Hives) 01/2021
1	Dizziness (Lightheadedness) 11/2018
1	Injection Site Reaction 11/2018
1	Multiple Sclerosis 05/2018
1	Body Weight (Weight, Body) 01/2018
1	Overweight 01/2018
1	IgG Deficiency 01/2017
1	Chronic Disease (Chronic Diseases) 06/2016
1	Fever (Fevers) 06/2016
1	Inflammation (Inflammations) 06/2016
1	Pain (Aches) 06/2016
1	Hematologic Neoplasms (Hematological Malignancy) 05/2014
1	Enteritis 01/2014
1	Primary Immunodeficiency Diseases 01/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2014
1	Abdominal Pain (Pain, Abdominal) 04/2012
1	Polymyositis 01/2011
1	Dermatomyositis (Dermatopolymyositis) 01/2011
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2011
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2007
1	Soft Tissue Infections 09/2004
1	Wiskott-Aldrich Syndrome 02/2002

Drug/Important Bio-Agent (IBA)

12	icatibantIBA 01/2022 - 09/2010
7	BradykininIBA 01/2022 - 09/2010
5	Kallikreins (Kallikrein)IBA 02/2024 - 01/2017
5	Plasma KallikreinIBA 11/2023 - 01/2017
5	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 01/2022 - 01/2014
5	lanadelumabIBA 01/2021 - 01/2017
3	Bradykinin B2 ReceptorIBA 01/2022 - 09/2015
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 04/2012
2	Monoclonal AntibodiesIBA 11/2018 - 01/2017
2	Immunoglobulin M (IgM)IBA 01/2017 - 01/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2014 - 01/2014
2	Immunoglobulins (Immunoglobulin)IBA 05/2014 - 01/2014
1	CRISPR-Associated Protein 9IBA 02/2024
1	sebetralstatIBA 11/2023
1	Antisense OligonucleotidesIBA 01/2022
1	ecallantide FDA Link 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021
1	Omalizumab (Xolair)FDA Link 01/2021
1	Non-Sedating Histamine H1 Antagonists (Histamine H1 Antagonists, Non Sedating)IBA 01/2021
1	KininsIBA 02/2019
1	Cladribine FDA LinkGeneric 05/2018
1	Alemtuzumab (Campath)FDA Link 05/2018
1	acivicin (AT 125)IBA 01/2018
1	berotralstatIBA 01/2018
1	EicosanoidsIBA 06/2016
1	LipidsIBA 06/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2014
1	AntibodiesIBA 05/2014
1	Anticonvulsants (Antiepileptic Drugs)IBA 05/2014
1	Rituximab (Mabthera)FDA Link 01/2014
1	conestat alfaIBA 01/2014
1	Phospholipases (Phospholipase)IBA 01/2014
1	Immunoglobulin A (IgA)IBA 01/2014
1	Immunoglobulin G (IgG)IBA 01/2014
1	Estrogens (Estrogen)FDA Link 04/2012
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2011
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2011
1	Complement C4 (Complement Component 4)IBA 04/2007
1	Hormones (Hormone)IBA 09/2004
1	Interferon-gamma (Interferon, gamma)IBA 01/2004
1	AutoantibodiesIBA 01/2004

Therapy/Procedure

11	Therapeutics 02/2024 - 09/2004
2	Drug Therapy (Chemotherapy) 01/2014 - 01/2004
1	Self Administration (Administration, Self) 07/2019
1	Injections 05/2018
1	Oral Administration 01/2018
1	Immunomodulation 01/2011
1	Debridement 09/2004
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2002